Vol 7, Supplement 3 (December 2015): Journal of Thoracic Disease [Abstract Book for the 6th International Thymic Malignancy Interest Group Annual Meeting (ITMIG 2015)]

Oral 1—Abstract Session 1: Molecular Biology and Chemotherapy

Oral 1.01. Phase II trial of amrubicin in patients with previously treated advanced thymic malignancies
Heather A. Wakelee, Sukhmani K. Padda, Matthew Burns, A. J. Spittler, Jonathan W. Riess, Melanie San Pedro-Salcedo, Kavitha J. Ramchandran, Matthew A. Gubens, Joel W. Neal, Patrick J. Loehrer Sr
Oral 1.02. Sunitinib in patients with advanced thymic epithelial tumors (TET)
Jordi Remon, Nicolas Girard, Julien Mazières, Eric Dansin, Eric Pichon, Julie Biemar, Catherine Dubos, Benjamin Besse
Oral 1.03. Frequent PD-L1 expression in thymic squamous cell carcinoma of Chinese patients
Hong Jian, Yongfeng Yu, Lan Shen, Shun Lu
Oral 1.04. MicroRNA networks: novel key regulators in thymic epithelial tumors
Mirella Marino, Federica Ganci, Teresa Bellissimo, Etleva Korita, Andrea Sacconi, Federica Mori, Enzo Gallo, Annamaria Cambria, Emanuele Russo, Marco Anile, Domenico Vitolo, Edoardo Pescarmona, Rosario Blandino, Francesco Facciolo, Federico Venuta, Giovanni Blandino, Francesco Fazi

Oral 2—Abstract Session 2: Treatment and Novel Approaches

Oral 2.01. Proton beam radiation therapy for adjuvant and definitive treatment of thymoma and thymic carcinoma
Jennifer H. Vogel, Abigail T. Berman, Taine T. Pechet, Levin P. William, Peter E. Gabriel, Sami Khella, Sunil Singhal, John C. Kucharczuk, Charles B. Simone II
Oral 2.02. The role of postoperative radiotherapy for stage I/II/III thymic tumor—results of chart database
Jian-Hua Fu, Qian-Wen Liu, Fu Yang, Wen-Tao Fang, Ke-Neng Chen, Zhen-Tao Yu, Yong-Tao Han, Yin Li, Li-Jie Tan, Lie-Wen Pang, Yi Shen, Gang Chen, Jin Xiang
Oral 2.03. S-1 salvage treatment for chemorefractory stage IV thymic carcinoma: a report of 19 cases
Changlu Wang
Oral 2.04. Expression and significance of c-kit and EMT molecules in thymic epithelial tumors
Rongjin Ye, Xiaofeng Li, Bin Zheng, Wei Zheng, Chun Chen

Oral 3—Abstract Session 3: Regional Trends

Oral 3.01. Malignant thymoma incidence in a Chinese population
Chunxiao Wu
Oral 3.02. Postoperative survival for patients with thymoma complicating myasthenia gravis—chart experience
Liewen Pang, Fangrui Wang
Oral 3.03. Increasing number of thymectomies performed in the United States
Jae Kim, Philip Ituarte, Dan Raz
Oral 3.04. The extent of lymph node dissection in thymic malignancies
In Kyu Park, Yoohwa Hwang, Samina Park, Eung Rae Kim, Chang Hyun Kang, Young Tae Kim

Oral 4—Abstract Session 4: Patient Evaluation

Oral 4.01. Comparison between computed tomography and magnetic resonance imaging in preoperative evaluation of thymic epithelial tumors
Marcelo Benveniste, Mylene Truong, Sonia L. Betancourt Cuellar, Brett W. Carter, Bradley Sabloff, Ana Paula A. Benveniste, Jingfei Ma, Bryan M. Fellman, Edith M. Marom
Oral 4.02. Dynamic contrast-enhanced MR imaging in risk stratification of thymic epithelial tumors
Yan Shen, Jianding Ye
Oral 4.03. Needs assessment and design of the first thymic malignancy and myasthenia gravis program
Abigail T. Berman, Neil Ravitz, Taine T. Pechet, Jennifer H. Vogel, Renae Judy, Evan Alley, Charles B. Simone II, Sami Khella
Oral 4.04. Emergency presentation of mediastinal tumors: a clinicopathological study
Abdulhadi Almutairi

Poster Session

P01. Long-term survival after surgical treatment of thymic carcinoma
Ke-Neng Chen, Hao Fu, Zhitao Gu, Wentao Fang, Hua J. Fu, Yi Shen, Yong-Tao Han, Zhen-Tao Yu, Yin Li, Li-Jie Tan, Liewen Pang
P02. Comparison a novel 3-hole surgery with VATS for myasthenia gravis: a retrospective study
Qiang Lu, Yongan Zhou, Juzheng Wang
P03. Thymic neuroendocrine tumors: analysis of factors affecting survival
Benny Weksler, Jennifer L. Sullivan
P04. Elevated serum lactate dehydrogenase level predicts both poor overall survival and short recurrence-free survival after resection of thymic carcinoma
Qian-Wen Liu, Jing Wen, Xin Wang, Hong Yang, Yi-Jun Zhang, Yi Hu, Kong-Jia Luo, Zi-Hui Tan, Jun-Ying Chen, Xia-Yu Fu, Jian-Hua Fu
P05. Low-dose radiotherapy for the treatment of pleural recurrence of thymic carcinoma
Changlu Wang, Lanting Gao
P06. A new surgical method for anterior mediastinum tumors: a 3-hole approach
Yongan Zhou, Qiang Lu, Juzheng Wang
P07. Effectiveness of cytotoxic agent etoposide after target therapy in advanced thymic tumors
Margaret Ottaviano, Vincenzo Damiano, Claudia von Arx, Irene Tucci, Lucia Nappi, Pasquale Rescigno, Giuliano Palumbo, Sabino De Placido, Giovannella Palmieri
P08. Somatostatin analogs plus prednisone in aggressive histotype and advanced stage of thymic epithelial tumors
Margaret Ottaviano, Vincenzo Damiano, Lucia Nappi, Pasquale Rescigno, Mirella Marino, Silvana Del Vecchio, Irene Tucci, Claudia von Arx, Giuliano Palumbo, Giovannella Palmieri
P09. Diagnosis of advanced thymic epithelial tumors in patients previously affected by thymic hyperplasia
Vincenzo Damiano, Margaret Ottaviano, Irene Tucci, Elide Matano, Sabino De Placido, Giovannella Palmieri
P10. Is the OctreoScan score a predictive factor of response to somatostatin analogs treatment?
Vincenzo Damiano, Margaret Ottaviano, Silvana Del Vecchio, Sabrina Segreto, Irene Tucci, Claudia von Arx, Giuliano Palumbo, Sara Pellegrino, Sabino De Placido, Mirella Marino, Giovannella Palmieri
P11. 18FDG-PET/CT for early prediction of response to first line platinum chemotherapy in advanced thymic epithelial tumors
Giovannella Palmieri, Margaret Ottaviano, Silvana Del Vecchio, Sabrina Segreto, Irene Tucci, Vincenzo Damiano
P12. Somatostatin analogs as maintenance therapy in heavily pretreated thymic epithelial tumors
Giovannella Palmieri, Margaret Ottaviano, Lucia Nappi, Pasquale Rescigno, Irene Tucci, Mirella Marino, Claudia von Arx, Giuliano Palumbo, Silvana Del Vecchio, Vincenzo Damiano
P13. Establishment and charactrization of a novel human thymoma cell line
Qiangling Sun, Wentao Fang, Zhitao Gu
P14. Feasibility of “subxiphoid and subcostal” approach in video-assisted thoracoscopic thymectomy for patients with myasthenia gravis
Yong Tang, Guibin Qiao
P15. The expression of Tc17 cells in thymoma accompany with autoimmune diseases or autoimmune disorders
Peng Zhang
P16. The impact of thymoma cell apoptosis after down Wnt4 gene
Peng Zhang
P17. Do associated auto-antibodies influence the outcome of myasthenia gravis after thymectomy?
Marlies Keijzers, Jans Damoiseaux, Alain Vigneron, Nicolas Bodart, Alfons Kessels, Anne-Marie Dingemans, Monique Hochstenbag, Jos Maessen, Marc De Baets
P18. Thoracoscopic complete thymectomy for thymoma
Takahiro Iida, Tadasu Kohno, Sakashi Fujimori, Takeshi Ikeda, Takashi Harano, Souichirou Suzuki, Emi Sakai
P19. Combined transcervical and bilateral-thoracoscopic extended thymectomy for thymoma with MG
Jian-Yong Ding, Liang Xue, Xuguang Pang
P20. Expression and clinical significance of autoimmune regulator in thymomas with autoimmune disease
Peng Zhang
P21. To explore the value of Qiangji Jianli method for the MG patients underwent extended thymectomy
Yanzhong Liu, Chi Yung Wang
P22. The clinical value of biomarker in the thymic tumors
Zhexin Wang, Wentao Fang, Zhitao Gu
P23. Tumor volume of thymic epithelial tumors based on who histological classification
Yukihisa Sato, Masahiro Yanagawa, Akinori Hata, Maki Hujihara, Yuka Hujita, Tomoko Gyobu, Ken Ueda, Osamu Honda, Katsuyuki Nakanishi, Noriyuki Tomiyama
P24. The predictive role of the WHO histological classification in the treatment of advanced thymoma
Tetsuzo Tagawa, Tatsuro Okamoto, Yosuke Morodomi, Eiji Iwama, Yoichi Nakanishi, Shinichiro Shimamatsu, Mitsuhiro Takenoyama, Yukito Ichinose, Masafumi Yamaguchi, Takashi Seto, Masakazu Katsura, Kazuki Takada, Yuzo Suzuki, Takatoshi Fujishita, Yoshihiko Maehara
P25. VATS combined with a subxiphoid incision: a novel approach for large thymoma
Xuguang Pang, Jian-Yong Ding, Liang Xue, Cheng Qian, Qun Wang
P26. Analysis of immune makers and clinical significance in thymomas with autoimmune disease in thymoma
Peng Zhang
P27. Induction but not extrapleural pneumonectomy may be important in the treatment for stage IVa thymoma
Xinghua Cheng, Changlu Wang, Wentao Fang, Haiquan Chen, Jianxin Shi
P28. Pridictors and management for the primary IVa thymoma
Lanting Gao, Changlu Wang
P29. Evolution of minimally invasive surgery in the management of thymic masses at a single institution
Anna L. W. Tam, Atasha Asmat, Aneez D. B. Ahmed
P30. A case of anterior mediastinitis and bilateral multiple lung abscesses occurring after TsTET
Yun Wang
P31. Salvage surgery for PMGCT: beneficial for persistent positive-marker patients?
Takashi Sakai, Tomoyuki Hishida, Genichiro Ishii, Keigo Sekihara, Tomohiro Miyoshi, Keiju Aokage, Junji Yoshida, Masahiro Tsuboi
P32. Comparing radiotherapy with free breathing and deep inspiration breath hold for thymic cancers
Kristoffer S. Rohrberg, Gedske Daugaard, Peter M. Petersen
P33. Predictive factors of extended thymectomy for myasthenia gravis
Naoya Himuro, Takao Minakata, Yutaka Oshima, Yuri Tomita, Daisuke Kataoka, Shigeru Yamamoto, Mitsutaka Kadokura
P34. The clinical analysis of subxiphoid approach of VATS anterior mediastinal mass extended resection
Chenhui Ni, Wei Zheng, Mingqiang Liang, Bin Zheng, Chun Chen
P35. Study on the loss of heterozygosity of microsatellite allele in thymic epithelial tumors
Peng Zhang
P36. Thoracoscopic resection of bulky thymoma using artificial pneumothorax
Hui Zhang, Miao Zhang, Xuefeng Pan
P37. Locally advanced thymoma-robotic approach
Belal B. Asaf, Arvind Kumar
P38. Reoperation for recurrent thymoma: a single-center experience from Nanchang
Yangchun Liu, Qing Lin, Li Ouyang, Ye Zhang, Quan Xu, Liru Chen
P39. Effects of TNIP1/TNFAIP3 expression: implications for myasthenia gravis
Yun Wang, Yingtsai Gung
P40. Does IL8 (CXCL8) have a role in thymoma progression and as a marker for relapse?
Yin Wu, Abhishek Das, Adrian Hayday, Rohit Lal, Deena Gibbons